Reduction of Preexisting AAV9 Antibody Titers Before Onasemnogene Abeparvovec Administration in Twins With Spinal Muscular Atrophy
{{output}}
Objectives: Preexisting immunity to adeno-associated viruses (AAVs) presents a major obstacle to eligibility for gene therapy. Methods: We dete... ...
